---
title: "Reverse Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing Reverse Total Shoulder Arthroplasty"
nct_id: NCT03617107
overall_status: UNKNOWN
sponsor: The Orthopaedic Research & Innovation Foundation
study_type: OBSERVATIONAL
primary_condition: Osteo Arthritis Shoulders
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03617107.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03617107"
ct_last_update_post_date: 2019-10-25
last_seen_at: "2026-05-12T06:33:01.685Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Reverse Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing Reverse Total Shoulder Arthroplasty

**NCT ID:** [NCT03617107](https://clinicaltrials.gov/study/NCT03617107)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 150
- **Lead Sponsor:** The Orthopaedic Research & Innovation Foundation
- **Conditions:** Osteo Arthritis Shoulders, Proximal Humeral Fracture, Rotator Cuff Tear, Rotator Cuff Tear Arthropathy
- **Start Date:** 2017-12-15
- **Completion Date:** 2020-12-31
- **CT.gov Last Update:** 2019-10-25

## Brief Summary

The purpose of this study is to evaluate reverse total shoulder arthroplasty patients preoperative objective measurements and operative objective measurements to determine if there is any effect to postoperative outcomes. Patients who were 18 years old or greater at the time of surgery were followed clinically and radiographically to determine best practice and optimal treatment and technique, risk and rate of complication, and postoperative outcomes.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

1. English speaking
2. \>18 years of age
3. Reverse TSA performed by principal investigator

Exclusion Criteria:

1. Non-English speaking
2. \<18 years of age
```

## Interventions

- **reverse total shoulder arthroplasty** (OTHER) — reverse total shoulder arthroplasty

## Primary Outcomes

- **total operative time** _(time frame: preoperative to up to 8 years postoperative)_ — minutes
- **amount of blood loss** _(time frame: preoperative to up to 8 years postoperative)_ — mls

## Secondary Outcomes

- **Patient Outcomes** _(time frame: preoperative to up to 8 years postoperative)_
- **Patient Outcomes** _(time frame: preoperative to up to 8 years postoperative)_

## Locations (1)

- The Orthopaedic Research & Innovation Foundation, Edgewood, Kentucky, United States

## Recent Field Changes (last 30 days)

- `results.hasResults` — added _(2026-05-12)_
- `locations.the orthopaedic research & innovation foundation|edgewood|kentucky|united states` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03617107.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03617107*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*